section name header

Y-Site Injection Compatibility (1:1 Mixture)

Sildenafil citrate

(Mfr: AUR)(Conc: 0.8 mg/mL)

QMark

Bumetanide

(Mfr: WW, HOS)(Conc: 0.25 mg/mL)

Remarks:

Inconsistent results from subvisible particle analyses. Microparticulates detected by 2 of 3 methods in 4 hr at 20 to 22°Ci

Ref:

3976